Atlas Trials

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors

Clinical trial NCT05544292 · COMPLETED

Trial details

NCT number
NCT05544292
Sponsor
Diakonhjemmet Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Immune-related Adverse Event
Start date
2018-03-05
Primary completion
2024-12-31
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.